妊娠对巴西结核病治疗结局的影响:2016-2022年全国监测数据分析
基于巴西卫生部2016-2022年监测数据,纳入11-49岁新诊断药物敏感结核病且接受一线方案治疗、有已知治疗结局的女性96 868例。多变量回归显示,妊娠与青少年失访(aOR 1.78)和死亡(aOR 2.35)风险升高相关,20-29岁和30-39岁孕妇失访风险升高(aOR分别为1.39和1.79),40-49岁孕妇死亡风险升高(aOR 1.66)。
要点
- 孕妇结核治疗成功率为76.6%,失访率19.1%,死亡率4.3%。
- 青少年孕妇失访aOR 1.78(95%CI 1.29-2.44),死亡aOR 2.35(95%CI 1.27-4.37)。
- 40-49岁孕妇死亡风险升高(aOR 1.66,95%CI 1.04-2.66)。
核心结论
- 分析显示妊娠与不良结核治疗结局存在显著关联,需为接受结核治疗的孕妇提供强化支持与监测,并需进一步研究明确原因。
研究设计与样本
- 使用巴西卫生部监测数据,纳入2016-2022年11-49岁新诊断药物敏感结核病、接受一线抗结核方案且有已知治疗结局的女性96 868例,采用多变量回归按年龄分层估计妊娠对失访和死亡的影响。
主要发现
- 96 868例女性中,孕妇1870例(1.9%),非孕妇79 361例(81.9%),妊娠状态未知15 637例(16.1%)。
- 孕妇中治疗成功1432例(76.6%),失访358例(19.1%),死亡80例(4.3%)。
- 非孕妇中治疗成功79 262例(83.4%),失访11 582例(12.2%),死亡4154例(4.4%)。
- 青少年中,妊娠与失访风险升高相关(aOR 1.78,95%CI 1.29-2.44),与死亡风险升高相关(aOR 2.35,95%CI 1.27-4.37)。
- 20-29岁和30-39岁孕妇较同龄非孕妇失访风险升高(aOR分别为1.39,95%CI 1.17-1.66和1.79,95%CI 1.42-2.25),40-49岁孕妇死亡风险升高(aOR 1.66,95%CI 1.04-2.66)。
临床怎么用
- 研究提示妊娠与结核治疗失访和死亡风险升高相关,照护者应为接受结核治疗的孕妇提供强化支持与监测。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: More than 200 000 pregnant people fall ill with tuberculosis (TB) annually. Little is known about the impact of pregnancy on TB outcomes. METHODS: This study used surveillance data from Brazil's Ministry of Health. We included women aged 11-49 years newly diagnosed with drug-susceptible TB disease between 2016 and 2022, treated with a first-line anti-TB regimen, and with a known treatment outcome. Using multivariable regression, we estimated the age-stratified effect of pregnancy on (1) loss to follow-up and (2) death during TB treatment. RESULTS: Of 96 868 women with TB, 1870 (1.9%) were pregnant, 79 361 (81.9%) were not pregnant, and 15 637 (16.1%) had unknown pregnancy status. Among pregnant women, 1432 (76.6%) experienced treatment success, 358 (19.1%), lost to follow-up, and 80 (4.3%) died. Among nonpregnant women, 79 262 (83.4%) experienced treatment success, 11 582 (12.2%) were lost to follow-up, and 4154 (4.4%) died. In adolescents, pregnancy conferred higher odds of loss to follow-up (adjusted odds ratio [aOR], 1.78; 95% confidence interval [CI]: 1.29-2.44) and death (aOR, 2.35; 95% CI: 1.27-4.37). Compared to nonpregnant women of the same age, pregnant women aged 20-29 and 30-39 years experienced more loss to follow-up (respectively: aOR, 1.39; 95% CI: 1.17-1.66 and aOR 1.79; 95% CI, 1.42-2.25), while those aged 40-49 years were more likely to die (aOR, 1.66; 95% CI: 1.04-2.66). CONCLUSIONS: Our analysis revealed a significant association between pregnancy and poor TB treatment outcomes, highlighting the need for care providers to offer enhanced support and monitoring for pregnant women undergoing TB treatment. Further research is needed to identify the underlying reasons for these findings.
引用
- Chiang SS, Campbell JR, Pelissari DM, et al. The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016-2022. Clin Infect Dis. 2026. PMID: 40327541. doi:10.1093/cid/ciaf233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。